Walmart Layoffs 2025: Should You Sell WMT Stock as Tariffs Drive the Retailer to Job Cuts?
In late May, Walmart announced plans to cut roughly 1,500 corporate jobs as part of a broader restructuring effort aimed at 'removing layers and complexity, speeding up decision‐making and helping associates innovate rapidly,' according to a memo from CTO Suresh Kumar and U.S. CEO John Furner. The layoffs, focused on its global tech teams, advertising arm, and e-commerce fulfillment operations, come alongside warnings that the retailer will have to raise prices if the highest‐impact tariffs remain in place. MarketWatch reports that the job cuts are 'another way to deal with tariffs.'
For investors weighing whether to hold or sell WMT stock, these moves could signal both short‐term headwinds and long‐term efficiency gains. Here's what to consider before deciding.
About WMT Stock
Walmart is an American retail powerhouse operating supercenters, discount department stores, and extensive grocery outlets worldwide. Over the past few decades, the company has grown into the largest retailer by revenue, known for its everyday low-price strategy. Currently, it owns 10,771 stores and clubs across 24 countries.
With a market capitalization of about $780 billion, Walmart's shares slid more than 22% from mid-February through early April as investors braced for tariff headwinds. Since hitting a low of $81 in early April, however, the stock has rallied by over 20% to around $97. Overall, the stock is up approximately 8% year-to-date, outperforming the broader market.
In terms of valuation, Walmart is currently trading at premium levels. Its trailing price-earnings ratio of 38x is significantly higher than the sector median of 16.5x as well as its historical norms of 26x. This means investors expect above-average growth but have less room for error.
Walmart Delivered Mixed Q1 Results
On May 15, the retail giant reported its Q1 results for fiscal year 2026. Despite beating earnings estimates, it was the weakest quarter since 2022. Walmart posted adjusted EPS of $0.61 that topped the $0.58 consensus by 5%, while revenue of $165.6 billion fell just shy of the $165.84 billion forecast. Notably, inventory climbed nearly 4% year over year, marking the first time since early 2022 that stockpiles have outpaced revenue growth, a reversal of the retailer's typical business cadence.
The e-commerce business reported revenue growth of 20% and turned profitable this quarter, thanks to higher delivery density, with U.S. and Sam's Club online operations in the black and international channels slightly unprofitable. Meanwhile, Walmart Connect, the company's advertising business, jumped 31% in the U.S. and 50% globally, highlighting its margin-rich contribution amid pressure on core retail margins.
Looking ahead, management reaffirmed full-year fiscal 2026 guidance for 3%–4% sales growth and expects Q2 sales to rise 3.5%–4.5%.
What Do Analysts Think About WMT Stock?
Wall Street analysts remain highly optimistic about Walmart's growth prospects, as reflected in a consensus 'Strong Buy' rating. Of 38 covering the stock, 32 rate it a 'Strong Buy,' five a 'Moderate Buy,' and one a 'Hold,' with no 'Sell' recommendations.
The average 12-month price target is $108.79, implying roughly 11% upside potential from here.
The Bottom Line
Walmart's 2025 corporate cuts and tariff-driven price hikes aim to shore up margins and boost efficiency, but risk straining staff and testing consumer loyalty. Strong e-commerce results, solid guidance, and widespread analyst support suggest WMT remains a buy-and-hold pick for those weathering near-term volatility.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
42 minutes ago
- CTV News
The Beer Store closes two locations in Windsor
The Beer Store seen on Goyeau Street in Windsor, Ont. (Robert Lothian/CTV News Windsor) Two locations in Windsor of The Beer Store are officially closed, effective Sunday. The two stores are at 790 Goyeau Street and 1780 College Avenue. The announcement was made earlier this year that nine total locations would be closing, including the two in Windsor. The other four locations in Windsor will remain open. 'The Beer Store is modernizing operations to meet the needs of marketplace – this means making the difficult decision to close some stores,' said Ozzie Ahmed, vice president of retail, when the announcement was made. 'We know this will be disappointing to many customers and our valued employees. We don't make this decision lightly; it is part of our ongoing commitment to business sustainability and serving the needs of our customers.' The Beer Store The Beer Store seen on College Avenue in Windsor, Ont. (Robert Lothian/CTV News Windsor) - With files from CTV News London's Bailey Shakyaver.
Globe and Mail
an hour ago
- Globe and Mail
2 Dividend Stocks to Buy for Decades of Passive Income
Key Points Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits for a long time to come. That's thanks to their solid businesses and promising product pipelines. In 2013, AbbVie (NYSE: ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (NYSE: ABT). Since then, both have produced strong returns and have been great picks for income-seeking investors, thanks to consistent payout hikes. That likely won't change soon. These healthcare leaders should continue to perform well and reward shareholders with dividend increases for a long time. Read on to find out more. 1. AbbVie AbbVie is a pharmaceutical leader with a large portfolio of approved products, none more important than a duo of immunology medicines: Skyrizi and Rinvoq. In the first quarter, the company's revenue increased by 8.4% year over year to $13.3 billion, while its adjusted earnings per share came in at $2.46, 6.5% higher than the year-ago period. These results are all the more impressive considering AbbVie faced a major patent cliff just two years ago; however, it has since recovered, largely thanks to Skyrizi and Rinvoq. The former generated $3.4 billion in sales during the period, representing a 70.5% year-over-year increase. Rinvoq's revenue came in at $1.7 billion, 57.2% higher than the year-ago period. Management predicts their combined annual sales will exceed $31 billion by 2027. Not only is that significantly higher than the $17.7 billion they racked up last year, it's also $4 billion higher than their previous guidance. Skyrizi and Rinvoq are expected to drive top-line growth well into the 2030s. Although they will eventually lose patent protection, they demonstrate AbbVie's ability to navigate even the biggest patent cliffs, a quality that is essential for any pharmaceutical company to thrive over the long term. AbbVie has other products that help drive revenue growth, and, equally important, it has a deep pipeline that it routinely strengthens through acquisitions. In March, the company announced a licensing deal with Denmark-based Gubra A/S for GUB014295, an investigational weight management therapy. AbbVie paid $350 million up front for this candidate, with potential milestones of $1.9 billion, not including royalties. AbbVie entered the fast-growing weight loss market with this move; GUB014295 might not pan out, but AbbVie's large pipeline, with approximately 90 products in development, should allow it to launch brand-new products frequently, navigate patent cliffs, and remain successful over the long run. Now turning to the company's dividend, AbbVie has increased its payouts by 310% since 2013. And counting the time it spent under Abbott Laboratories' name, AbbVie is a Dividend King with 53 consecutive years of payout increases. These facts, from AbbVie's underlying business to the company's dividend track record, point to a company capable of sustaining a passive income program for a long time. 2. Abbott Laboratories Abbott Laboratories is best known for its leadership in the medical device space, where it markets dozens of products across multiple therapeutic areas. The company also operates a diagnostic business and has a presence in the pharmaceutical and nutrition industries. Abbott Laboratories' operations are diversified, which can help it overcome challenges in specific segments. That's one of the company's strengths. Here's another: Abbott Laboratories has been a leader in the highly regulated healthcare sector for decades. The company has built a solid reputation with physicians and consumers, all of whom are more likely to gravitate toward the brands they know and trust. In the medical device field, Abbott is a trusted brand. And thanks to its vast portfolio, it generates consistent revenue and earnings. Abbott's biggest growth driver in recent years has been its diabetes care segment, led by its continuous glucose monitoring (CGM) franchise, the FreeStyle Libre. As the company noted, the FreeStyle Libre has become the most successful medical device in history in terms of dollar sales. That's no small feat. Yet there is still massive whitespace ahead, since only a small portion of the world's diabetics use CGM technology despite its advantages. Abbott's work in this niche should provide a powerful long-term tailwind, but there will be many others. The company boasts other growth drivers, including its structural heart segment, where it markets a range of successful devices, such as its MitraClip device, a leader in its mitral valve repair niche. Beyond any single product, Abbott Laboratories has a proven track record as an innovator and should continue launching newer and better ones. Lastly, Abbott is also a Dividend King, and over the past decade, it has increased its payouts by almost 146%. Abbott Laboratories' business is built to last. Investors who purchase the company's shares today can expect consistent dividend growth over the long term. Should you invest $1,000 in AbbVie right now? Before you buy stock in AbbVie, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor 's total average return is1,060% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 30, 2025
Globe and Mail
2 hours ago
- Globe and Mail
Carney drops digital services tax, LNG Canada starts exports to Asia and auto CEOs ask for EV mandate changes: Business and investing stories for the week of July 6
Getting caught up on a week that got away? Here's your weekly digest of The Globe's most essential business and investing stories, with insights and analysis from the pros, stock tips, portfolio strategies and more. Prime Minister Mark Carney briskly walked back Canada's digital services tax (DST) on foreign tech giants after U.S. President Donald Trump ended trade talks. The White House said that Mr. Carney 'caved' during a Sunday phone call with Mr. Trump and negotiations would resume between the two countries. Speaking to reporters in Ottawa, Mr. Carney declined to explain what Canada received in return for scrapping the tax, but said Canada and the U.S. aim to have a deal by July 21. The digital services tax would have imposed a 3-per-cent levy on Canadian revenue exceeding $20-million earned by major tech companies such as Amazon, Google parent Alphabet, Meta, Uber and Airbnb with at least $1.1-billion in global revenue. This would have included revenue from search engines, social-media platforms and online marketplaces. The tax was enacted by Canada last year with the first payments due to be collected June 30, mere hours before Mr. Carney scrapped it. This week, Prime Minister Mark Carney met with auto sector chief executives from Ford Canada, Stellantis Canada and General Motors of Canada as the Canadian and U.S. governments try to reach a trade deal that might end auto tariffs, among other levies. The CEOs are urging Ottawa to repeal federal regulations that require one in five vehicles (20 per cent) sold starting in 2026 to be zero-emission models. This rises to 60 per cent by 2030 and 100 per cent by 2035. As Steven Chase and Eric Atkins report, automakers warn that electric-vehicle sales in Canada are waning this year and it would be impossible to reach the zero-emission vehicle (ZEV) mandate targets, especially with federal EV incentives for car buyers on pause. The automakers also say they won't be able to meet next year's target, and that consumers – not government – should decide what is available on the car lots. Canada is grappling with Mr. Trump's 50-per-cent tariffs on steel and aluminum, and a 25-per-cent tariff on autos. Canada's trade deficit with the world narrowed in May, falling to $5.9-billion from a record $7.6-billion in April, according to Statistics Canada data. Tariffs continued to weigh on exports to the United States, Nojoud Al Mallees reports, already slowing down the Canadian economy. Forecasters expect the economy shrank in the second quarter, and for the trade challenges to continue exerting upward pressure on the jobless rate. Still, the only thing that shimmered in Statistics Canada's latest release of trade numbers was soaring exports of unwrought gold, silver and platinum. The rise in prices for the shiny metals has increasingly skewed Canada's trade numbers. In fact, the country's trade deficit widened to $10.3-billion after stripping out imports and exports of the gold category. Jason Kirby takes a closer look at the numbers in this week's Decoder series. A ship carrying the first load of liquefied natural gas from Canada's first LNG export terminal left for Asia earlier this week. The GasLog Glasgow departed from Kitimat, B.C., on Monday, embarking on a journey across the Pacific Ocean nearly seven years after the export terminal's construction began. As Brent Jang reports, this moment ushers a new era in energy exports at a time when Canada seeks to diversify markets away from the United States. Once the Kitimat terminal's first phase is in full swing, there will be about 170 vessels a year transporting LNG to Asian markets. LNG Canada, whose largest partner is Shell with a 40-per-cent stake, is mulling expanding operations that could double the plant's capacity to 28 million tonnes a year. In contrast, the first LNG export facility in the U.S. mainland began operating in 2016, and another seven U.S. sites have opened since then. Climate activists and environmental think tanks say the world needs to focus on renewable energy, not on fossil fuels such as LNG. The Southeast is booming. The region has been growing faster than the rest of the U.S. for quite some time, and its outperformance has ramped up since 2019, according to the Federal Reserve Bank of Atlanta. This power shift is highly relevant for Canadians, because while states close to the border might suffer from a trade war with Canada, all the growth in the Southeast could help the United States offset any tariff trauma. The boom in the Southeast has become a secret weapon in Trump's trade war, and it allows the White House to push the limits. Tim Kiladze took a road trip through the region that has quietly become America's economic engine. He drove 500 kilometres through the U.S. Southeast – from Charlotte, to Charleston, to Savannah – talking to small business owners, bankers, industrial chief executive officers and everyday people. Get the rest of the questions from the weekly business and investing news quiz here, and prepare for the week ahead with The Globe's investing calendar.
